North America Ambulatory Infusion Pumps Market Size Analysis by Product Type (Devices, Accessories & Consumables), Route of Administration (Intravenous, Subcutaneous, Epidural), Application (Pain Management, Diabetes, Oncology, Neonatology, Gastroenterology, General Anesthesia, Emergency Medicine), Distribution Channel (Direct, Indirect) - Industry Revenue Estimation and Demand Forecast to 2030

Market Overview

The North American ambulatory infusion pumps market was valued at $953.1 million in 2021, and the market size is predicted to reach $1,989.8 million by 2030, advancing at a CAGR of 8.5% during 2021–2030. The market is driven by the surging prevalence of chronic diseases, rising geriatric population, increasing diabetic population, and growing demand for ambulatory services.

The market is also growing due to the rising prevalence of diabetes, obesity, and other chronic and lifestyle-associated conditions among the elderly in the U.S. Furthermore, the rise in the volume of surgical procedures and chemotherapy treatments is expected to drive the market in the coming years.

The regional market is also growing due to the rising awareness of diabetes management and increasing healthcare spending. Obesity and insulin resistance have been considered independent risk factors for diabetes; thus, the rising obese population is driving the demand for insulin delivery devices, thereby propelling the ambulatory infusion pumps market in the region.

Moreover, the trend of home infusion therapies is growing with the strengthening emphasis on the cost-effectiveness of healthcare. Thus, there is a continuous shift of patients from expensive sites, including emergency and other hospital departments, to less-costly alternative sites, such as clinics/centers and homes. An average home infusion costs around $230, while hospital-based infusions cost $590 per patient per infusion. This equals an average saving of around $360 per patient per infusion. Additionally, such alternative sites and home-based care offer greater convenience. Hence, due to the rising availability of advanced, cost-effective ambulatory infusion pumps, home infusion therapy is rapidly gaining acceptance among North American patients.

In the wake of the COVID-19 pandemic, several governments implemented strategic measures to sustain the economy and overcome the health crisis. Additionally, in view of the rising healthcare burden, the demand for advanced drug delivery systems has increased considerably.

The lockdowns and partial factory closures had slightly negatively impacted the import & export and distribution of such products, which hindered the growth of the market during the second quarter of 2020. However, with the lifting of the lockdowns and the reopening of international airports and ports, product supply resumed.

Accessories & Consumables Held Larger Share in Market

Of the product types, accessories & consumables held the larger share in the ambulatory infusion pumps market of the region. This is primarily due to their repetitive purchases and availability of a broad range of accessories & consumables across the region.

Devices also held a substantial share, over 40%, in the market in 2021. This is majorly attributed to the rising demand for these pumps for convenience while administering drugs for a range of conditions and their high availability.

Diabetes Application Holds Dominating Share

Diabetes accounted for the largest revenue share, of around 30%, in the application segment of the North American ambulatory infusion pumps market in 2021. This can be attributed to the growing prevalence of diabetes and its complications in the region. Over 96 million people aged 18 years or older have prediabetes, which is 38.0% of the adult U.S. population. As it delivers doses of insulin at specific times, an infusion pump replaces the need for multiple daily injections with a continuous insulin infusion. Thus, the rise in the number of diabetes cases over time is expected to fuel the demand for ambulatory infusion pumps. Furthermore, the innovations in wearable diabetes management devices and their extended infusion periods are responsible for their rising adoption.

Growing Demand for Ambulatory Services

Due to the growing population and strain on the healthcare system, ambulatory services, a type of outpatient care, are steadily growing in popularity in North America. This is essentially because these services are cost-effective and more convenient compared to those offered by traditional hospitals.

Consequently, the number of ambulatory surgical centers (ASCs) across the U.S. has increased significantly over the last few years. The popularity of ASCs can also be attributed to the shorter stays, lower risk of infections, faster recovery, and innovative technologies they offer. In this regard, the preference for ambulatory services over hospital care is growing as a result of the lack of visitation time and a high case burden. Thus, the increasing demand for ambulatory services for diabetes care, chemotherapy, and other medical procedures influences the use of infusion pumps in the region.

Explore more about this report - Request free sample

U.S. Is Larger Market for Ambulatory Infusion Pumps in North America

The U.S. held the larger share, over 90%, in 2021, because of the presence of major players, developed healthcare infrastructure, favorable reimbursement policies, and surging prevalence of chronic diseases. In addition to this, the development of alternative healthcare settings and penetration of different home infusion services are contributing to the growth of the market. Furthermore, the presence of a large number of hospitals in the U.S. is expected to continue driving the regional market growth. According to the American Hospital Association (AHA), a total of 6,093 hospitals were operational in the U.S. in 2021, including 2,960 non-government not-for-profit community hospitals and 1,228 investor-owned (for-profit) community hospitals.

Top Ambulatory Infusion Pump Manufactures in North America Are:

• B. Braun Melsungen AG
• Moog Inc.
• WalKMed LLC
• Medtronic plc
• Fresenius Medical Care AG & Co. KGaA (Fresenius Kabi)
• Becton, Dickinson and Company
• Repro Med Systems Inc. (KORU Medical Systems)
• Avanos Medical Inc.
• ICU Medical Inc.
• Eitan Medical
• Ace Medical Co. Ltd.

Market Size Breakdown by Segment

The report offers a comprehensive market segmentation analysis along with market estimation for the period 2017-2030.

Based on Product Type

• Devices
• Accessories & Consumables

Based on Route of Administration

• Intravenous
• Subcutaneous
• Epidural

Based on Application

• Pain Management
• Diabetes
• Oncology
• Neonatology
• Gastroenterology
• General Anesthesia
• Emergency Medicine

Based on Distribution Channel

• Direct
• Indirect

Regional Analysis

• U.S.
• Canada